Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Basel | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Pharmacists are in the best position to counsel and educate patients on anticoagulant agents such as NOACs. This should enable patients to play a more active role in their treatment and ultimately enhance adherence behaviour. However, educational elements should be targeted to knowledge. Thus, the investigators will develop and validate a questionnaire that can assess knowledge about NOACs
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Education |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Education | Behavioral | Patients will receive several questionnaires to fill in. Knowledge about NOACs will be assessed with a newly developped questionnaire and an educational program will be dispensed while analysing the answers (reactive educational program). |
| Measure | Description | Time Frame |
|---|---|---|
| Validation of the new questionnaire assessed by questionnaire | Patients will rate on a 4-point likert scale feasibility, acceptability and comprehension of the new questionnaire immediately after the questionnaire had been filled in the first time. | measured once at visit 1 (baseline) |
| Sensitivity of the new questionnaire | Number of correct/incorrect answers measured at visit 2 before and after the educational program has been dispensed (7 days after visit 1) | 7 days after visit 1, before and after the educational program |
| Test retest validity of the new questionnaire | Number of correct/incorrect answers measured at visit 1 and 2 (0 respectively 7 days after visit 1) | 7 days |
| Measure | Description | Time Frame |
|---|---|---|
| Patient's adherence assessed by questionnaire | change in adherence between visits 1 (baseline) and visit 3 | 14 days |
| Patient's satisfaction assessed by questionnaire | change in satisfaction between visits 1 (baseline) and visit 3 |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients having an anticoagulation identification card | assessed once at visit 1 (baseline assessment) |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients having a prescription for NOACs
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kurt Hersberger, Prof. | University of Basel | Study Chair |
| Isabelle Arnet, PD. | Pharmaceutical Care Research Group, University of Base | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Basel, Pharmaceutical Care Research Group | Basel | Canton of Basel-City | 4056 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001281 | Atrial Fibrillation |
| D011655 | Pulmonary Embolism |
| D020246 | Venous Thrombosis |
| ID | Term |
|---|---|
| D001145 | Arrhythmias, Cardiac |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D004522 | Educational Status |
| ID | Term |
|---|---|
| D012959 | Socioeconomic Factors |
| D011154 | Population Characteristics |
Not provided
Not provided
Not provided
Not provided
Not provided
| 14 days |
| Patient's health literacy assessed by questionnaire | assessed once at visit 1 (baseline assessment) |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D004617 | Embolism |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D013927 | Thrombosis |